Akimoto Tetsu, Yamazaki Tomoyuki, Kohara Marina, Nakagawa Saki, Kanai Yoshihiko, Izawa Sayoko, Yamamoto Hisashi, Nakazawa Eiko, Masuda Takahiro, Kobayashi Takahisa, Saito Osamu, Muto Shigeaki, Kusano Eiji, Nagata Daisuke
Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan.
Division of Thoracic Surgery, Department of Medicine, Japan Community Health Care Organization Utsunomiya Hospital, Utsunomiya, Japan.
Clin Med Insights Case Rep. 2017 Oct 16;10:1179547617735818. doi: 10.1177/1179547617735818. eCollection 2017.
Peritoneal dialysis has been a widely accepted modality for treating end-stage kidney disease, but a regular dialysis schedule can be seriously disrupted by various comorbid conditions requiring surgical intervention. A 40-year-old woman who had been receiving peritoneal dialysis was sequentially but separately complicated by pleuroperitoneal communication and ovarian cancer. Despite the need for temporary interruption of her peritoneal dialysis schedule, it was successfully resumed after the relevant surgeries for each disease. Several concerns regarding overall postoperative dialytic management strategies, including how to deal with the peritoneal dialysis catheter during the postoperative period as well as how long peritoneal dialysis should be interrupted, which remain an unresolved issue in the field of nephrology, are also discussed.
腹膜透析一直是治疗终末期肾病的一种广泛接受的方式，但常规的透析计划可能会因需要手术干预的各种合并症而受到严重干扰。一名接受腹膜透析的40岁女性先后但分别并发了胸膜腹膜瘘和卵巢癌。尽管需要暂时中断她的腹膜透析计划，但在针对每种疾病进行相关手术后，该计划成功恢复。文中还讨论了关于术后透析总体管理策略的几个问题，包括术后如何处理腹膜透析导管以及腹膜透析应中断多长时间，这些问题在肾脏病领域仍是未解决的问题。
